Our Approach

We evaluate how the order and timing of prior therapies may shape future treatment effectiveness and strategic options.

We assess cumulative radiation exposure to identify potential safety limits and implications for future therapeutic planning.

We analyze how prior systemic treatments may influence biological response patterns and subsequent treatment pathways.

We identify clinical and biological signals that may suggest elevated progression risk or treatment resistance dynamics.

We map factors that may limit future treatment options, including prior toxicities, organ tolerance, and clinical eligibility considerations.

We review medical documentation for alignment across pathology, imaging, and clinical records to support coherent strategic interpretation.